{"id":80014,"date":"2024-12-03T16:23:43","date_gmt":"2024-12-03T16:23:43","guid":{"rendered":"https:\/\/www.cofb.org\/?p=80014"},"modified":"2024-12-03T16:36:11","modified_gmt":"2024-12-03T16:36:11","slug":"la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","title":{"rendered":"La prevenci\u00f3n del c\u00e1ncer de pulm\u00f3n y los \u00faltimos avances cient\u00edficos en este \u00e1mbito, puntos principales de una nueva tertulia de actualidad"},"content":{"rendered":"

El pasado 14 de noviembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) <\/strong>organiz\u00f3, junto con la Fundaci\u00f3n Oncolliga<\/a>, la tertulia de actualidad \u201c\u00daltimos avances cient\u00edficos y prevenci\u00f3n en c\u00e1ncer de pulm\u00f3n\u201d <\/strong>con el patrocinio de Johnson & Johnson<\/a>. La sesi\u00f3n, moderada por el tesorero del COFB, Miquel Recasens<\/strong>, fue a cargo de la Dra.<\/strong> Enriqueta Felipe<\/strong>, jefe de la secci\u00f3n de Oncolog\u00eda M\u00e9dica de la Unidad de Tumores Tor\u00e1cicos del Vall d'Hebron de Barcelona; Gemma Puig<\/strong>, farmac\u00e9utica, t\u00e9cnica del \u00c1rea del Medicamento del Departamento de Salud; Maria Assumpci\u00f3 Vil\u00e0<\/strong>, presidenta de la Fundaci\u00f3n Oncolliga; y la Dra. \u00c0ngels Arcusa<\/strong>, presidenta del Comit\u00e9 Cient\u00edfico de la Fundaci\u00f3n Oncolliga.<\/p>\n\n\n\n

\"\"<\/a>
De izquierda a derecha: la Dra. Enriqueta Felip, Gemma Puig y Miquel Recasens. <\/figcaption><\/figure>\n\n\n\n

Los objetivos <\/strong>de la tertulia de actualidad fueron identificar las caracter\u00edsticas<\/strong> y tipos de c\u00e1nceres de pulm\u00f3n<\/strong>, conocer las tendencias<\/strong> y avances cient\u00edficos<\/strong> en el c\u00e1ncer de pulm\u00f3n, revisar las novedades terap\u00e9uticas<\/strong> y promover las estrategias de prevenci\u00f3n<\/strong>.<\/p>\n\n\n\n

La Dra. \u00c0ngels Arcusa<\/strong>, presidenta del Comit\u00e9 Cient\u00edfico de la Fundaci\u00f3n Oncolliga inici\u00f3 la tertulia de actualidad explicando cu\u00e1l es la misi\u00f3n principal de la Fundaci\u00f3n<\/strong>: \u201ces un conjunto de personas al servicio de otras personas; lo que se pretende es acompa\u00f1ar y ayudar a los pacientes con c\u00e1ncer ya sus familias<\/strong>\u201d. La doctora hizo especial \u00e9nfasis en que el c\u00e1ncer no es una enfermedad de una sola persona sino que \u201cenferma y lo sufren todas aquellas personas que le rodean<\/strong>\u201d. Por tanto, el objetivo de la Fundaci\u00f3n Oncolliga, seg\u00fan indic\u00f3 la Dra. Arcusa, es realizar actuaciones de \u201cdifusi\u00f3n, comunicaci\u00f3n, informaci\u00f3n, concienciaci\u00f3n del c\u00e1ncer y de lo que representa en nuestra sociedad, en todo lo que son las medidas de prevenci\u00f3n, de tratamiento y de acompa\u00f1amiento\u201d.<\/p>\n\n\n\n

\"La<\/a>
La Dra. \u00c0ngels Arcusa y Miquel Recasens en un momento de la conferencia. <\/figcaption><\/figure>\n\n\n\n

Espec\u00edficamente sobre el c\u00e1ncer de pulm\u00f3n<\/strong>, la Dra. \u00c0ngels Arcusa, asegur\u00f3 que en los \u00faltimos 20-22 a\u00f1os, el c\u00e1ncer de pulm\u00f3n "ha hecho un cambio de 180\u00b0", ya que "de una enfermedad que pr\u00e1cticamente no hac\u00edamos casi seguimiento porque los pacientes mor\u00edan a los cuatro, cinco, seis meses, hemos pasado a largas supervivencias de a\u00f1os incluso en enfermos metast\u00e1ticos y tambi\u00e9n hemos cronificado esta enfermedad<\/strong>\u201d.<\/p>\n\n\n\n

Avances cient\u00edficos y prevenci\u00f3n en el c\u00e1ncer de pulm\u00f3n<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3n, intervino la Dra.<\/strong> Enriqueta Felipe<\/strong>, jefe de la secci\u00f3n de Oncolog\u00eda M\u00e9dica de la Unidad de Tumores Tor\u00e1cicos del Vall d'Hebron de Barcelona, que profundiz\u00f3 en el c\u00e1ncer de pulm\u00f3n <\/strong>en cuanto a los avances cient\u00edficos<\/strong> y la prevenci\u00f3n de esta enfermedad<\/strong>. \u201cEl c\u00e1ncer de pulm\u00f3n es una enfermedad de elevada incidencia<\/strong>, ya que es el segundo c\u00e1ncer m\u00e1s diagnosticado en el mundo<\/strong> y es la principal causa de muerte por c\u00e1ncer<\/strong>\u201d. La doctora detall\u00f3 la incidencia y mortalidad de este c\u00e1ncer en Espa\u00f1a, las principales \u00e1reas de intervenci\u00f3n, los cinco factores de riesgo evitables, dos estudios de cribados de c\u00e1ncer de pulm\u00f3n, los retos que supone la implementaci\u00f3n del cribado y abordaje multidisciplinar del c\u00e1ncer.<\/p>\n\n\n\n

\"La<\/a>
La Dra. Enriqueta Felipe durante su exposici\u00f3n. <\/figcaption><\/figure>\n\n\n\n

Para cerrar su presentaci\u00f3n, la Dra. Felipe, remarc\u00f3 que \u201chay que garantizar que el paciente tenga en todo momento: agilidad en los procesos<\/strong>, comunicaci\u00f3n<\/strong> con los profesionales, informaci\u00f3n clara <\/strong>sobre opciones de tratamiento<\/strong> y pron\u00f3stico<\/strong>, informaci\u00f3n<\/strong> sobre los efectos secundarios<\/strong> y sobre los h\u00e1bitos de vida<\/strong> recomendados y soporte integral<\/strong>\u201d.<\/p>\n\n\n\n

Los nuevos medicamentos para tratar el c\u00e1ncer de pulm\u00f3n<\/strong><\/h2>\n\n\n\n

A continuaci\u00f3n, la farmac\u00e9utica y t\u00e9cnica del \u00c1rea del Medicamento del Departamento de Salud, Gemma Puig<\/strong>, especific\u00f3 cu\u00e1les son los nuevos f\u00e1rmacos para tratar el c\u00e1ncer de pulm\u00f3n<\/strong>. As\u00ed pues, la farmac\u00e9utica ofreci\u00f3 una visi\u00f3n general de las novedades recientes<\/strong>, de la autorizaci\u00f3n<\/strong> y acceso a los medicamentos<\/strong> y los nuevos retos que se plantean<\/strong>.<\/p>\n\n\n\n

\"Gemma<\/a>
Gemma Puig impartiendo su conferencia sobre los nuevos medicamentos para tratar el c\u00e1ncer de pulm\u00f3n.<\/figcaption><\/figure>\n\n\n\n

Puig coment\u00f3 que ha habido mucha innovaci\u00f3n en el c\u00e1ncer de pulm\u00f3n<\/strong>; \u201cdesde finales de 2023 hasta octubre de 2024, se han autorizado 12 indicaciones<\/strong>\u201d. Asimismo, resalt\u00f3 que \u201chay una evoluci\u00f3n del tratamiento del c\u00e1ncer de pulm\u00f3n<\/strong> hacia el abordaje del estadio precoz, pero tambi\u00e9n en primera l\u00ednea metast\u00e1tica\u201d. Por \u00faltimo, remarc\u00f3 que "el elevado coste de los nuevos tratamientos puede comprometer a sostenibilidad del sistema", por eso, dijo que "hay que encontrar el equilibrio entre estos avances terap\u00e9uticos y estas mejoras con la sostenibilidad del sistema".<\/p>\n\n\n\n

Importancia del soporte en el enfermo oncol\u00f3gico<\/strong><\/h2>\n\n\n\n

Por \u00faltimo, la presidenta de la Fundaci\u00f3n Oncolliga, Maria Assumpci\u00f3 Vil\u00e0<\/strong>, cerr\u00f3 la tertulia de actualidad. \u201cA\u00f1os atr\u00e1s cuando o\u00edamos hablar de c\u00e1ncer de pulm\u00f3n, le asoci\u00e1bamos directamente con la muerte\u201d<\/strong>, indic\u00f3 Vil\u00e0, que a\u00f1adi\u00f3 que, en la actualidad, "hay muchas esperanzas"<\/strong>.En este sentido, destac\u00f3 la importancia de la investigaci\u00f3n.<\/p>\n\n\n\n

\"\"<\/a>
Maria Assumpci\u00f3 Vil\u00e0 y Miquel Recasens durante la tertulia de actualidad.<\/figcaption><\/figure>\n\n\n\n

\u201cLas fundaciones como Oncolliga estamos aqu\u00ed para ayudar a aquellas personas que han sufrido o sufren la enfermedad ofreciendo apoyo social, psicol\u00f3gico y t\u00e9cnico<\/strong>\u201d, record\u00f3 Vil\u00e0.<\/p>\n\n\n\n

<\/div>
\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div>\n

Coorganiza:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div><\/section>\n\n\n\n
<\/div>
\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div><\/div>\n\n\n\n
<\/div>\n

Patrocina:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div><\/section>","protected":false},"excerpt":{"rendered":"

El pasado 14 de noviembre, el Colegio de Farmac\u00e9uticos de Barcelona (COFB) organiz\u00f3, junto con la Fundaci\u00f3n Oncolliga, la tertulia de actualidad "\u00daltimos avances cient\u00edficos y prevenci\u00f3n en c\u00e1ncer de pulm\u00f3n" con el patrocinio de Johnson & Johnson. La sesi\u00f3n, moderada por el tesorero del COFB, Miquel Recasens, fue a [\u2026]<\/p>","protected":false},"author":3,"featured_media":80024,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[64,5181,723,5182,18,19,53,68,69,70,76,724,59,264,140],"class_list":["post-80014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-atencio-farmaceutica","tag-avencos-cientifics","tag-cancer","tag-cancer-pulmo","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-formacio","tag-oficina-de-farmacia","tag-oncologia","tag-pacients","tag-prevencio","tag-tertulia-dactualitat"],"yoast_head":"\nLa prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3"\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-03T16:23:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-03T16:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat\",\"datePublished\":\"2024-12-03T16:23:43+00:00\",\"dateModified\":\"2024-12-03T16:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"},\"wordCount\":954,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"aven\u00e7os cient\u00edfics\",\"c\u00e0ncer\",\"c\u00e0ncer pulm\u00f3\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"Oficina de farm\u00e0cia\",\"oncologia\",\"pacients\",\"prevenci\u00f3\",\"tert\u00falia d'actualitat\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\",\"url\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\",\"name\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"datePublished\":\"2024-12-03T16:23:43+00:00\",\"dateModified\":\"2024-12-03T16:36:11+00:00\",\"description\":\"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\\\"\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg\",\"width\":2560,\"height\":1440,\"caption\":\"La Dra. Enriqueta Felip en un moment de la seva exposici\u00f3.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","og_locale":"es_ES","og_type":"article","og_title":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","og_url":"https:\/\/www.cofb.org\/es\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2024-12-03T16:23:43+00:00","article_modified_time":"2024-12-03T16:36:11+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Berta Mart\u00ednez","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat","datePublished":"2024-12-03T16:23:43+00:00","dateModified":"2024-12-03T16:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"},"wordCount":954,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","keywords":["Atenci\u00f3 farmac\u00e8utica","aven\u00e7os cient\u00edfics","c\u00e0ncer","c\u00e0ncer pulm\u00f3","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","Oficina de farm\u00e0cia","oncologia","pacients","prevenci\u00f3","tert\u00falia d'actualitat"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","url":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/","name":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d'una nova tert\u00falia d\u2019actualitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","datePublished":"2024-12-03T16:23:43+00:00","dateModified":"2024-12-03T16:36:11+00:00","description":"El passat 14 de novembre, el COFB va organitzar la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\"","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg","width":2560,"height":1440,"caption":"La Dra. Enriqueta Felip en un moment de la seva exposici\u00f3."},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2024\/12\/03\/la-prevencio-del-cancer-de-pulmo-i-els-darrers-avencos-cientifics-punts-principals-duna-nova-tertulia-dactualitat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"La prevenci\u00f3 del c\u00e0ncer de pulm\u00f3 i els darrers aven\u00e7os cient\u00edfics en aquest \u00e0mbit, punts principals d’una nova tert\u00falia d\u2019actualitat"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2024\/12\/COFB_CANCER-PULMO_02122024_2.3-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 14 de novembre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar, juntament amb la Fundaci\u00f3 Oncolliga, la tert\u00falia d\u2019actualitat \u201cDarrers aven\u00e7os cient\u00edfics i prevenci\u00f3 en c\u00e0ncer de pulm\u00f3\u201d amb el patrocini de Johnson & Johnson. La sessi\u00f3, moderada pel tresorer del COFB, Miquel Recasens, va anar a […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=80014"}],"version-history":[{"count":38,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80014\/revisions"}],"predecessor-version":[{"id":80069,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/80014\/revisions\/80069"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/80024"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=80014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=80014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=80014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}